New Research Study on Parkinson’s Disease Treatment Market: Key Players involved in the research – GSK, Merck, Novartis AG, Teva

Parkinson’s Disease Treatment Market

The study covers key regions that includes South America (Brazil, Argentina, Rest of South America) , Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific) , Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe) , MEA (Middle East, Africa) , North America (United States, Canada, Mexico)and important players such as GSK (United Kingdom) , Merck (United States) , Novartis AG (Switzerland) , Teva (Israel) , Boehringer Ingelheim (Germany) , Impax Laboratories (United States) , Abbvie (United States) , Valeant Pharmaceuticals (Canada) , Lundbeck (Denmark) and Sun Pharma (India).

Request a sample report @ https://www.htfmarketreport.com/sample-report/1569512-global-parkinson-s-disease-treatment-market-7

Summary
Market Overview:

Parkinson’s disease is a type of chronic and progressive movement disorder that includes malfunction and death of vital nerves cells in the brain, termed as neurons. Some of these dying neurons yield dopamine, a chemical that sends messages to the part of the brain, which controls coordination and movement. As Parkinson’s disease progresses, the amount of dopamine produced in the brain decreases, leaving a person unable to control movement normally. Some of the studies have found that genetic factors, and environmental factors can also be caused of Parkinson’s disease. Environmental factors such as exposure to environmental toxin or injury may possess the risk of Parkinson’s disease. According to National Institute of Environmental Health Sciences, 0.5 million people of the US currently have the disease, and prevalence is rising with the population ages. The major endeavour of the Parkinson’s illness treatment is to offer control on symptoms and signs, for instance, difficulty with walking, shakiness in hands, slowness of movement, and so on.. Some of the key players profiled in the study are GSK (United Kingdom) , Merck (United States) , Novartis AG (Switzerland) , Teva (Israel) , Boehringer Ingelheim (Germany) , Impax Laboratories (United States) , Abbvie (United States) , Valeant Pharmaceuticals (Canada) , Lundbeck (Denmark) and Sun Pharma (India).

Market Dynamics:

Market Trend
• According to Parkinson.org More than 10 million people a year are living with Parkinson’s disease
• Medications of individual costs around 2500 USD a year, and therapeutic surgery costs around 100,000 USD for individual

Market Drivers
• Growth in Aging Population and the Associated Increase in the Prevalence of Parkinson’s disease
• Government Funding for Research

Opportunities
• Patent Expiry of Branded Drugs
• Strong Drug Pipeline
Major Market Developments:

H. Lundbeck A/S (Lundbeck) again expanded its pipeline of clinical development projects with the initiation of a phase I study of a potential new treatment of Parkinson’s disease. The compound — Lu AF28996— is invented by Lundbeck and will now be studied in healthy volunteers as first part of its clinical development.
Target Audience:

Parkinson’s disease treatment product manufacturers , Parkinson’s disease treatment dealers and suppliers , Human identification service providers , Parkinson’s disease associations , Academic institutions , Venture capitalists , Consulting firms and Government bodies

The following are the major objectives of the study
• To define, describe, and forecast the Global Parkinson’s Disease Treatment market on the basis of product [] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Parkinson’s Disease Treatment market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America) , Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific) , Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe) , MEA (Middle East, Africa) , North America (United States, Canada, Mexico)
• To strategically profile the key players and analysing their market shares and core competencies in the Parkinson’s Disease Treatment industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

While framing the research framework, major and emerging players operating in the Parkinson’s Disease Treatment market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1569512-global-parkinson-s-disease-treatment-market-7

Table of Contents

1 Market Overview

    1.1   Parkinson’s Disease Treatment Introduction

    1.2 Market Analysis by Type

    1.3 Market Analysis by Applications

    1.4 Market Analysis by Regions

        1.4.1 North America (United States, Canada and Mexico)

            1.4.1.1 United States Market States and Outlook (2013-2023)

            1.4.1.2 Canada Market States and Outlook (2013-2023)

            1.4.1.3 Mexico Market States and Outlook (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy)

            1.4.2.1 Germany Market States and Outlook (2013-2023)

            1.4.2.2 France Market States and Outlook (2013-2023)

            1.4.2.3 UK Market States and Outlook (2013-2023)

            1.4.2.4 Russia Market States and Outlook (2013-2023)

            1.4.2.5 Italy Market States and Outlook (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

            1.4.3.1 China Market States and Outlook (2013-2023)

            1.4.3.2 Japan Market States and Outlook (2013-2023)

            1.4.3.3 Korea Market States and Outlook (2013-2023)

            1.4.3.4 India Market States and Outlook (2013-2023)

            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

        1.4.4 South America, Middle East and Africa

            1.4.4.1 Brazil Market States and Outlook (2013-2023)

            1.4.4.2 Egypt Market States and Outlook (2013-2023)

            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

            1.4.4.4 South Africa Market States and Outlook (2013-2023)

            1.4.4.5 Nigeria Market States and Outlook (2013-2023)

    1.5 Market Dynamics

        1.5.1 Market Opportunities

        1.5.2 Market Risk

        1.5.3 Market Driving Force

2 Manufacturers Profiles

        2.1.1 Business Overview

        2.1.2   Parkinson’s Disease Treatment Type and Applications

        2.1.3   Parkinson’s Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global   Parkinson’s Disease Treatment Market Competition, by Manufacturer

    3.1 Global   Parkinson’s Disease Treatment Sales and Market Share by Manufacturer (2016-2017)

    3.2 Global   Parkinson’s Disease Treatment Revenue and Market Share by Manufacturer (2016-2017)

    3.3 Global   Parkinson’s Disease Treatment Price by Manufacturer (2016-2017)

    3.4 Market Concentration Rate

        3.4.1 Top 3   Parkinson’s Disease Treatment Manufacturer Market Share in 2017

        3.4.2 Top 5   Parkinson’s Disease Treatment Manufacturer Market Share in 2017

    3.5 Market Competition Trend

….Continued

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1569512

About Author: 
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Media Contact
Company Name: HTF Market Intelligence Consulting Private Limited
Contact Person: Craig Francis
Email: Send Email
Phone: 2063171218
Address:Unit No. 429, Parsonage Road
City: Edison
State: New Jersey
Country: United States
Website: https://www.htfmarketreport.com/sample-report/1569512-global-parkinson-s-disease-treatment-market-7